Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies

Clinical trial NCT00446342 · COMPLETED

Trial details

NCT number: NCT00446342
Sponsor: Sunesis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-lymphoid Malignancies Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Multiple Myeloma

Start date: 2007-02-01
Primary completion: 2008-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.